Literature DB >> 3409270

Alterations in cerebrospinal fluid uridine, hypoxanthine, and xanthine in head-injured patients.

R A Mueller1, M J Rosner, J N Ghia, S K Powers, E R Kafer, R D Hunt.   

Abstract

1. Examination of the cerebrospinal fluid (CSF) of head-injured patients reveals that the concentration of intraventricular xanthine is elevated and that of uridine is decreased relative to those of adult lumbar CSF. 2. No correlations were observed between CSF lactate and CSF hypoxanthine, xanthine, or uridine, suggesting that changes in purine metabolites and the pyrimidine nucleoside do not index similar cellular events as does lactic acid production. 3. Ventricular CSF from hydrocephalic infants had uridine and hypoxanthine concentrations not significantly different from those of normal adult lumbar CSF, but xanthine was significantly elevated. 4. Since uridine has anticonvulsant properties and is a crucial substrate for cerebral metabolism, it may be useful to evaluate this pyrimidine for use in the management of patients with head injury.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3409270     DOI: 10.1007/bf00711249

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  12 in total

1.  Hypoxanthine as a measurement of hypoxia.

Authors:  O D Saugstad
Journal:  Pediatr Res       Date:  1975-04       Impact factor: 3.756

2.  Anticonvulsant effects of uridine: comparative analysis of metrazol and penicillin induced foci.

Authors:  C A Roberts
Journal:  Brain Res       Date:  1973-06-15       Impact factor: 3.252

3.  Cerebrospinal fluid hypoxanthine and xanthine concentrations as indicators of metabolic damage due to raised intracranial pressure in hydrocephalic children.

Authors:  S D Levin; J K Brown; R A Harkness
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-07       Impact factor: 10.154

4.  Cerebrospinal fluid concentrations of hypoxanthine, xanthine, uridine and inosine: high concentrations of the ATP metabolite, hypoxanthine, after hypoxia.

Authors:  R A Harkness; R J Lund
Journal:  J Clin Pathol       Date:  1983-01       Impact factor: 3.411

5.  Protein fractions of lumbar, cisternal, and ventricular cerebrospinal fluid. Separate areas of reference.

Authors:  B Weisner; W Bernhardt
Journal:  J Neurol Sci       Date:  1978-07       Impact factor: 3.181

6.  Interaction of uridine with GABA binding sites in cerebellar membranes of the rat.

Authors:  P Guarneri; R Guarneri; C Mocciaro; F Piccoli
Journal:  Neurochem Res       Date:  1983-12       Impact factor: 3.996

7.  Intravenous uridine treatment antagonizes hypoglycaemia-induced reduction in brain somatostatin-like immunoreactivity.

Authors:  L F Agnati; K Fuxe; P Eneroth; I Zini; A Härfstrand; R Grimaldi; M Zoli
Journal:  Acta Physiol Scand       Date:  1986-04

8.  Purine and pyrimidine base and nucleoside concentrations in human cerebrospinal fluid and plasma.

Authors:  J T Eells; R Spector
Journal:  Neurochem Res       Date:  1983-11       Impact factor: 3.996

9.  The concentrations of xanthine and hypoxanthine in cerebrospinal fluid as therapeutic guides in hydrocephalus.

Authors:  M Castro-Gago; S Lojo; R Del Rio; A Rodriguez; I Novo; S Rodriguez-Segade
Journal:  Childs Nerv Syst       Date:  1986       Impact factor: 1.475

10.  The metabolism of purine and pyrimidine nucleotides in rat cortex during insulin-induced hypoglycemia and recovery.

Authors:  A G Chapman; E Westerberg; B K Siesjö
Journal:  J Neurochem       Date:  1981-01       Impact factor: 5.372

View more
  2 in total

1.  Opposite alterations in cerebrospinal fluid uridine after severe cerebral ischemia or intrathecal blood injection.

Authors:  R A Mueller; T J McCown; R D Hunt; C Lundberg; G R Breese
Journal:  Cell Mol Neurobiol       Date:  1990-09       Impact factor: 5.046

Review 2.  Physiological concentrations of purines and pyrimidines.

Authors:  T W Traut
Journal:  Mol Cell Biochem       Date:  1994-11-09       Impact factor: 3.396

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.